CSL PLASMA

Serial Number 97618260
731

Registration Progress

Application Filed
Oct 4, 2022
Under Examination
Feb 27, 2024
Approved for Publication
Jan 2, 2024
Published for Opposition
Jan 2, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Aug 27, 2025 30 days

Trademark Image

CSL PLASMA

Basic Information

Serial Number
97618260
Filing Date
October 4, 2022
Published for Opposition
January 2, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jan 27, 2025
Application
Pending
Classes
035 036 040 041
+1 more

Rights Holder

CSL Limited

99
Address
45 Poplar Road
Parkville, Victoria 3052
AU

Ownership History

CSL Limited

Original Applicant
99
Parkville, Victoria AU

CSL Limited

Owner at Publication
99
Parkville, Victoria AU

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
30 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
August 27, 2025
Extension Available
Until February 27, 2025

Application History

26 events
Date Code Type Description Documents
Mar 4, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 27, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 27, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 13, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 28, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 28, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 28, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 28, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 25, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 25, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 26, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 26, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 26, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 19, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 7, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance
Class 036
Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients
Class 040
Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma
Class 041
Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions
Class 042
Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Providing medical and scientific research information in the field of pharmaceuticals and blood plasma; Providing scientific information in the field of health care developments, blood plasma conditions, and new medical therapies; scientific information services in the field of health care developments, blood plasma conditions, and new medical therapies provided via the Internet; providing research information on donation of human blood for medical research

Classification

International Classes
035 036 040 041 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PLASMA"